We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MabCure Inc (CE) | USOTC:MBCI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2011
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number 333-141131
MABCURE INC.
(Exact name
of Registrant as specified in its charter)
Nevada | 20-4907813 |
(State or other jurisdiction of incorporation or | (IRS Employer Identification No.) |
organization) |
760 Parkside Avenue #208, Brooklyn, New York
11226
(Address of principal executive offices) (zip code)
(914) 595-6342
(Registrants telephone
number, including area code)
N/A
(Former name, former address and
former fiscal year, if changed since last report)
Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X] No
[ ]
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
Yes [X] No
[ ]
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated filer [ ] | Smaller reporting company [X] |
(Do not check if a smaller reporting company) |
Indicate by check mark whether the Registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).
Yes [
] No [X]
State the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date:
As of August 15, 2011, there were 63,565,065 shares of the Registrant's common stock issued and outstanding.
EXPLANATORY NOTE
The sole purpose of this Amendment to the Registrant’s Quarterly Report on Form 10-Q for the period ended June 30, 2011 (the “10-Q”), is to furnish the Interactive Data File exhibits pursuant to Rule 405 of Regulation S-T. No other changes have been made to the 10-Q, and this Amendment has not been updated to reflect events occurring subsequent to the filing of the 10-Q.
Item 6. Exhibits
Exhibit No. |
Description |
|
|
3.1 |
Articles of Incorporation (Incorporated by reference from our Registration Statement on Form SB-2 filed on March 8, 2007). |
|
|
3.2 |
Bylaws (Incorporated by reference from our Registration Statement on Form SB-2 filed on March 8, 2007). |
|
|
3.3 |
Certificate of Change (Incorporated by reference from our Quarterly Report on Form 10-QSB filed on November 20, 2007). |
|
|
3.4 |
Certificate of Correction (Incorporated by reference from our Quarterly Report on Form 10-QSB/A filed on November 23, 2007). |
|
|
3.5 |
Articles of Merger (Incorporated by reference from our Current Report on Form 8-K filed on January 24, 2008). |
4.1 |
Specimen ordinary share certificate (Incorporated by reference from our Registration Statement on Form SB-2 filed on March 8, 2007). |
|
|
10.1 |
Investment Agreement, dated as of January 18, 2011, between Registrant and Centurion Private Equity, LLC (incorporated by reference from our Current Report on Form 8-K filed on January 20, 2011). |
|
|
10.2 |
Registration Rights Agreement, dated as of January 18, 2011, between Registrant and Centurion Private Equity, LLC (incorporated by reference from our Current Report on Form 8-K filed on January 20, 2011). |
|
|
10.3 |
Securities Purchase Agreement, dated as of January 18, 2011, between Registrant and Centurion Private Equity, LLC (incorporated by reference from our Current Report on Form 8-K filed on January 20, 2011). |
|
|
10.4 |
Debenture dated as of January 18, 2011, between Registrant and Centurion Private Equity, LLC (incorporated by reference from our Current Report on Form 8-K filed on January 20, 2011). |
|
|
31.1* |
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Dr. Amnon Gonenne. |
|
|
31.2* |
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Ron Kalfus. |
|
|
32.1* |
Section 906 Certification of the Sarbanes-Oxley Act of 2002 of Dr. Amnon Gonenne. |
|
|
32.2* |
Section 906 Certification of the Sarbanes-Oxley Act of 2002 of Ron Kalfus. |
101** | Interactive data files pursuant to Rule 405 of Regulation S-T** |
* These exhibits were previously included in MabCure Inc.'s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011, filed with the Securities and Exchange Commission on August 22, 2011.
** Filed with this Form 10-Q/A for MabCure Inc..
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: August 25, 2011
MABCURE INC.
/s/ Dr. Amnon Gonenne
Dr. Amnon
Gonenne
President, Chief Executive Officer and a member of the Board of
Directors
(who also performs as the Principal Executive Officer)
August
25, 2011
/s/ Ron Kalfus
Ron Kalfus
Chief
Financial Officer
(who also performs as Principal Financial Officer and
Principal Accounting Officer)
August 25, 2011
1 Year MabCure (CE) Chart |
1 Month MabCure (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions